Patrick F. Smith

Patrick F. Smith

President, Certara Drug Development SolutionsatCertara· In proxies 2022–2024

Pay in FY2024-16% from the year before · Certara stock -39.5% the same year

Patrick F. Smith was paid $2.0M in FY2024 (Dec), down 16%. Certara stock fell 39.5% that year.

Pay$100 in the stock at the end of FY21 → $37
Pay is from the Summary Compensation Table of each Certara proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CertaraPublic company · 4 yr
    • President, Certara Drug Development Solutions2022 – Present · 4 yrStock in role -61%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?